Deven Choksey prefers Sun Pharma, Cipla for fresh buying; sees upside in Indian IT

Deven Choksey, Managing Director at DRChoksey Finserv, continues to hold Divi's Labs and Laurus Labs but recommends waiting for corrections before buying them. Choksey also remains positive on Indian IT companies, citing growing AI-related order inflows, while advising investors to wait for lower valuations in jewellery retailers such as Titan and Kalyan Jewellers.